<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="113178">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01629862</url>
  </required_header>
  <id_info>
    <org_study_id>8354706</org_study_id>
    <nct_id>NCT01629862</nct_id>
  </id_info>
  <brief_title>Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea</brief_title>
  <official_title>Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will examine the possible synergistic effects of obstructive sleep apnea
      (OSA) and type II diabetes mellitus (DM) on vascular functioning by performing a two-part
      investigation:

        -  A cross-sectional study comparing subjects with OSA+DM, OSA only, DM only, and healthy
           controls.

        -  A three-month randomized placebo-controlled trial of continuous positive airway
           pressure (CPAP) in subjects with OSA+DM.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in brachial artery flow-mediated dilation.</measure>
    <time_frame>Between baseline &amp; 3-month follow-up.</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Active CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Therapeutic continuous positive airway pressure (CPAP).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham CPAP</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sham (non-therapeutic) continuous positive airway pressure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous positive airway pressure</intervention_name>
    <description>CPAP at therapeutic pressure; ResMed S9 device in fixed pressure mode (Sydney, Australia).</description>
    <arm_group_label>Active CPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham continuous positive airway pressure</intervention_name>
    <description>CPAP at non-therapeutic pressure; ResMed S9 device using a ResMed sham mask (Sydney, Australia).</description>
    <arm_group_label>Sham CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OSA subjects: apnea-hypopnea index &gt;=10 and &lt;100

          -  DM subjects: clinical diagnosis of DM and glycated hemoglobin &lt; 8.0%

        Exclusion Criteria:

          -  Hematocrit &lt; 32

          -  Pregnancy

          -  Infectious/collagen vascular/hepatic or renal/cardiopulmonary disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aristidis Veves, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sanjay R Patel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaylee J Klingensmith, BS</last_name>
    <phone>412-246-6009</phone>
    <email>kjm94@pitt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sanjay R Patel, MD, MS</last_name>
    <phone>412-692-2035</phone>
    <email>patelsr2@upmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brigham &amp; Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessie P Bakker, PhD</last_name>
      <phone>617-732-5987</phone>
      <email>jpbakker@bwh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Jessie P Bakker, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aristidis Veves, MD</last_name>
      <phone>617-632-7075</phone>
      <email>aveves@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Aristidis Veves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 31, 2016</lastchanged_date>
  <firstreceived_date>May 8, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Sanjay R Patel</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
